Vol 12, No 5 (May 31, 2023): Translational Lung Cancer Research

Original Article

Trends in women’s representation as lead authors in high impact journals of lung cancer
Ni Dai, Junqiang Li, Lixia Ren
Blood tumor mutational burden and dynamic changes in circulating tumor DNA predict response to pembrolizumab treatment in advanced non-small cell lung cancer
Simone Stensgaard, Astrid Thomsen, Sofie Helstrup, Peter Meldgaard, Boe S. Sorensen
Genomic alterations dissection revealed MUC4 mutation as a potential driver in lung adenocarcinoma local recurrence
Chongze Yuan, Xingxin Yao, Pengfei Dai, Yue Zhao, Yihua Sun
The radioprotectant nano-genistein enhances radiotherapy efficacy of lung tumors in mice
Michael D. Kaytor, Artur A. Serebrenik, Karen Lapanowski, Debra McFall, Matthew Jones, Benjamin Movsas, Charles B. Simone II, Stephen L. Brown
BRCA mutations detected by tumour next-generation sequencing in non-small cell lung cancer: impact on response to therapy and disease course
Roi Tschernichovsky, Itamar Averbuch, Daniel Alex Goldstein, Raz Mutai, Elizabeth Dudnik, Ofer Rotem, Smadar Laufer-Geva, Nir Peled, Yael Goldberg, Alona Zer
Radiomic biomarkers from chest computed tomography are assistive in immunotherapy response prediction for non-small cell lung cancer
Kimberly E. Schroeder, Luna Acharya, Hariharasudan Mani, Muhammad Furqan, Jessica C. Sieren
Clinical and prognostic significance of detecting CEA, EGFR, LunX, c-met and EpCAM mRNA-positive cells in the peripheral blood, tumor-draining blood and bone marrow of non-small cell lung cancer patients
Alona Rehulkova, Josef Chudacek, Andrea Prokopova, Monika Vidlarova, Jana Stranska, Jiri Drabek, Jana Potockova, Radek Trojanec, Jana Vrbkova, Josef Skarda, Tomas Bohanes, Marek Szkorupa, Benjamin Tolmaci, Jiri Klein, Josef Srovnal, Marian Hajduch
Inhibition of BPHL inhibits proliferation in lung carcinoma cell lines
Pengfei Ren, Jianxue Zhai, Xuelian Wang, Yucheng Yin, Zuju Lin, Kaican Cai, Haofei Wang
Harmine loaded Au@MSNs@PEG@Asp6 nano-composites for treatment of spinal metastasis from lung adenocarcinoma by targeting ANXA9 in vivo experiment
Houlei Wang, Fancheng Chen, Annan Hu, Haifeng Liang, Yun Liang, Nagashree Seetharamu, Huiren Wang, Jian Dong
Effects of a ground-glass opacity component on the recurrence and survival of pathological stage IA3 lung adenocarcinoma: a multi-institutional retrospective study
Shao-Jun Xu, Rui-Qin Chen, Jia-Hua Tu, Cheng-Xiong You, Chao Chen, Zhi-Fan Zhang, Duilio Divisi, Marcello Migliore, Stefano Bongiolatti, Marion Durand, Masaaki Sato, Hiroaki Kuroda, Chao-Fu Yang, Shao-Bin Yu, Shu-Chen Chen
Targeting complement C5a to improve radiotherapy sensitivity in non-small cell lung cancer
Meng Yuan, Chenlin Wang, Yanan Wu, Lili Qiao, Guodong Deng, Ning Liang, Fangjie Chen, Li Liu, Yanfei Chen, Yunxin Yang, Hang Wang, Tong Liu, Xiaofan Yang, Yingying Zhang, Yajuan Lv, Rafal Suwinski, Pingping Hu, Yan Zhang, Jiandong Zhang
Comparative efficacy and safety of multitarget angiogenesis inhibitor combined with immune checkpoint inhibitor and nivolumab monotherapy as second-line or beyond for advanced lung adenocarcinoma in driver-negative patients: a retrospective comparative cohort study
Lian Yu, Jianlin Xu, Rong Qiao, Hua Zhong, Wolfgang M. Brueckl, Runbo Zhong
Assessing how lung cancer screening guidelines contribute to racial disparities in screening access
Tara Ivic-Pavlicic, Shivam Joshi, Angelo Zegarelli, Emanuela Taioli